| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.87T | 16.73T | 15.44T | 15.83T | 12.25T | 9.10T |
| Gross Profit | 5.31T | 4.36T | 4.63T | 5.73T | 3.46T | 2.53T |
| EBITDA | 5.34T | 4.74T | 4.83T | 5.47T | 3.74T | 2.75T |
| Net Income | 2.70T | 2.29T | 2.45T | 2.83T | 1.72T | 1.13T |
Balance Sheet | ||||||
| Total Assets | 21.54T | 20.97T | 19.23T | 19.90T | 17.69T | 18.23T |
| Cash, Cash Equivalents and Short-Term Investments | 1.79T | 1.71T | 383.17B | 826.21B | 175.96B | 791.95B |
| Total Debt | 3.29T | 3.20T | 2.61T | 3.36T | 4.14T | 6.01T |
| Total Liabilities | 4.97T | 4.49T | 3.80T | 5.44T | 5.69T | 7.70T |
| Stockholders Equity | 14.31T | 14.22T | 13.31T | 12.49T | 10.30T | 9.02T |
Cash Flow | ||||||
| Free Cash Flow | 2.76T | 1.78T | 1.62T | 2.20T | 1.56T | 1.42T |
| Operating Cash Flow | 4.25T | 3.26T | 3.28T | 3.51T | 2.65T | 2.45T |
| Investing Cash Flow | -1.06T | -504.37B | -1.18T | -493.96B | -598.43B | -930.70B |
| Financing Cash Flow | -2.42T | -1.43T | -2.54T | -2.38T | -2.67T | -1.25T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €2.46B | 11.08 | 20.72% | 6.43% | 15.89% | 21.52% | |
75 Outperform | $3.08B | 7.91 | 21.70% | 5.40% | 24.70% | 62.15% | |
74 Outperform | S$516.48M | 5.37 | 8.46% | 2.74% | 13.03% | 35.10% | |
68 Neutral | S$498.09M | 14.15 | 10.03% | 3.52% | -4.54% | -35.71% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $3.55B | 6.35 | 8.32% | 2.92% | 16.86% | 252.80% | |
62 Neutral | €450.20M | 5.87 | 7.17% | 0.61% | 47.72% | 16.14% |